Reactivation rates in patients using biological agents, with resolved HBV infection or isolated anti-HBc IgG positivity

BACKGROUND/AIMS: Tumor necrosis factor-α (TNF-α) inhibitors and ustekunimab are widely used in autoimmune diseases. It is known that these biological agents cause the reactivation of hepatitis B virus (HBV). There is no standardized strategy to prevent the reactivation in patients with evidence of a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Turk J Gastroenterol
Autors principals: Solay, Aslı Haykır, Acar, Ali, Eser, Fatma, Kuşcu, Ferit, Tütüncü, Emin Ediz, Kul, Gülnur, Şentürk, Gönül Çiçek, Gürbüz, Yunus
Format: Artigo
Idioma:Inglês
Publicat: Turkish Society of Gastroenterology 2018
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6284614/
https://ncbi.nlm.nih.gov/pubmed/30260778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/tjg.2018.18032
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars